TRAF3IP3 was previously reported as an adapter protein that plays essential roles in innate and adaptive immunity and could also respond to viral infection,[5, 30] indicating its potential adjuvant role in hosts in cancer therapy. This evidence concerns the gene TRAF3IP3 and cancer.